Ginkgo Bioworks Holdings, Inc. (DNA) vs MiMedx Group, Inc (MDXG)
Ginkgo Bioworks Holdings, Inc. and MiMedx Group, Inc are both Biotechnology companies. Ginkgo Bioworks Holdings, Inc. and MiMedx Group, Inc are of similar size ($686.5M and $683.6M). Ginkgo Bioworks Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; MiMedx Group, Inc trades at 117×. MiMedx Group, Inc grew revenue faster over the last twelve months: −2.36% against −37.0%. MiMedx Group, Inc has the higher net margin (1.76% vs −219.6%) and the higher return on invested capital (5.62% vs −161.9%). Across the 18 metrics below, MiMedx Group, Inc leads on 14 and Ginkgo Bioworks Holdings, Inc. on 4.
Valuation
Profitability
| Metric | DNA | MDXG | Biotechnology median |
|---|---|---|---|
| Gross margin | 68.04% | 78.85% | 65.16% |
| Operating margin | (231.13%) | 2.46% | 0.00% |
| Net margin | (219.60%) | 1.76% | 0.00% |
| Free cash flow margin | (131.57%) | 12.51% | 0.00% |
| Return on equity | (56.29%) | 2.88% | (57.72%) |
| Return on assets | (26.19%) | 2.18% | (49.22%) |
| Return on invested capital | (161.94%) | 5.62% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack